NYU Langone Health New York, New York
Associate Professor, Division of Hematology and Medical Oncology Department of Medicine
Understanding how nerves regulate and promote breast cancer metastasis.
Cancer cells create a complex environment around themselves, the tumor microenvironment, that helps them grow and spread to other parts of the body. Recent research has shown that cells lining blood vessels (endothelial cells) and immune cells in this environment play a significant role in promoting the spread of breast cancer. It was previously believed that more blood vessels around tumors simply supplied them with more oxygen and nutrients, aiding their growth. Now, it has been discovered that these blood vessels also send signals that actively encourage cancer cells to spread to new locations. Nerves in tumors were previously thought to be passive, simply providing routes for cancer cells to move along. Recently, studies have shown that nerves can help initiate tumors in some cancers. More innervation in these tumors is linked to higher chances of recurrence and poorer survival rates. It is not fully understood, however, how neurons regulate metastasis and how innervation changes as tumors become metastatic. Drs. Comen and Tavazoie are working toward understanding this connection.
Drs. Comen and Tavazoie have discovered that breast tumors are frequently innervated by sensory nerves and that the amount of nerve input correlates with how likely the cancer is to spread. Using both patient data and a breast cancer model, they showed that sensory nerves actively support tumor growth and metastasis. When the team removed tumor innervating sensory nerves using a targeted approach, tumor growth slowed, and lung metastases were significantly reduced. They also developed a new co-culture system showing that sensory neurons help cancer cells grow and spread—even without direct contact—through the release of a still-unknown molecule. These findings reveal a new and important role for nerves in breast cancer and suggest that blocking this communication could be a new strategy to prevent metastasis.
Drs. Comen and Tavazoie aim to identify the molecule released by sensory nerves that helps breast cancer cells grow and test its role in metastasis. The team will determine the cancer cell receptor through which this molecule signals. They will also study when in metastatic progression nerves have the greatest impact—during tumor growth, invasion, or spread—and whether immune cells are involved. Finally, Drs. Comen and Tavazoie will investigate whether and how signals from blood vessels help guide nerves into tumors.
Elizabeth Comen, MD is a medical oncologist at NYU Langone Health’s Perlmutter Cancer Center with a practice devoted to the study and treatment of patients with all stages of breast cancer. Dr. Comen earned her BA from Harvard College and her MD from Harvard Medical School. She completed residency at Mount Sinai Hospital and fellowships in medical oncology and advanced breast medicine at Memorial Sloan Kettering Cancer Center, where she then held a faculty position. She has presented her research many times at the American Society of Clinical Oncology (ASCO) Annual Meeting and the San Antonio Breast Cancer Symposium. She has also been awarded several peer-reviewed grants, including the ASCO Young Investigator Award.
2013
The Lampert Foundation Award
The Rockefeller University New York, New York
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.